Current Issue 28 March 2012, Vol. 316, No. 2

Issue Highlights

  • SUMOylation in carcinogenesis
    28 March 2012(Vol. 316 | No. 2 | Pages 113-125)

    Kira Bettermann, Martin Benesch, Serge Weis, Johannes Haybaeck

  • Intussusceptive microvascular growth in tumors
    28 March 2012(Vol. 316 | No. 2 | Pages 126-131)

    Domenico Ribatti, Valentin Djonov

  • Lipocalin 2 in cancer: When good immunity goes bad
    28 March 2012(Vol. 316 | No. 2 | Pages 132-138)

    Jeffrey J. Rodvold, Navin R. Mahadevan, Maurizio Zanetti

  • Estrogen induces endometrial cancer cell proliferation and invasion by regulating the fat mass and obesity-associated gene via PI3K/AKT and MAPK signaling pathways
    24 January 2012

    Zhenbo Zhang, Dongmei Zhou, Yunli Lai, Yongjuan Liu, Xiang Tao, Qianqian Wang, Guixu Zhao, Hongqin Gu, Hong Liao, Yaping Zhu, Xiaowei Xi, Youji Feng

  • Pyrvinium pamoate inhibits proliferation of myeloma/erythroleukemia cells by suppressing mitochondrial respiratory complex I and STAT3
    24 January 2012

    Yasuo Harada, Isao Ishii, Kiyohiko Hatake, Tadashi Kasahara

  • CD49f-based selection of circulating tumor cells (CTCs) improves detection across breast cancer subtypes
    24 January 2012

    Bianca Mostert, Jaco Kraan, Anieta M. Sieuwerts, Petra van der Spoel, Joan Bolt-de Vries, Wendy J.C. Prager-van der Smissen, Marcel Smid, Annemieke M. Timmermans, John W.M. Martens, Jan W. Gratama, John A. Foekens, Stefan Sleijfer

  • Live-attenuated measles virus vaccine confers cell contact loss and apoptosis of ovarian cancer cells via ROS-induced silencing of E-cadherin by methylation
    24 January 2012

    Shengtao Zhou, Yuhua Li, Fuqiang Huang, Boya Zhang, Tao Yi, Zhengyu Li, Hong Luo, Xiang He, Qian Zhong, Ce Bian, Xiaojuan Lin, Xiaorong Qi, Ping Liu, Canhua Huang, Xia Zhao, Yuquan Wei

  • BH3 profiling – Measuring integrated function of the mitochondrial apoptotic pathway to predict cell fate decisions
    24 January 2012

    Victoria Del Gaizo Moore, Anthony Letai

  • View More Articles in Press...

On the Cover


Cover Image

Journal Ranking

Impact Factor: 4.864

Journal Access

Full-text articles are available from 1995 to the present. Access to abstracts is complimentary. Access to full text is limited to print subscribers. Register or login to:

Activate Online Access

Publishing Information

Cancer Letters is published by Elsevier.


Access this journal onSciVerse ScienceDirect
Print or Share This Page

About Cancer Letters

Cancer Letters is an international journal that considers full-length articles and Mini Reviews in the broad area of basic and translational oncology. Additionally, Special Issues highlight topical areas in cancer research. Basic areas of interest to a broad readership of Cancer Letters include the molecular genetics and cell biology of cancer, radiation biology, molecular pathology, hormones and cancer, viral oncology, metastasis, and chemoprevention. The journal places emphasis on experimental therapeutics, particularly targeted therapies for personalized cancer medicine.

Sponsored Articles

Cancer Letters offers authors or their institutions the option to sponsor non-subscriber access to their articles on Elsevier's electronic publishing platforms. For more information please click here.